Effects of Sacubitril/Valsartan on Neprilysin Targets and The Metabolism of Natriuretic Peptides in Chronic Heart Failure: A Mechanistic Clinical Study
Hélène Nougue(Délégation Paris 5), Damien Logeart(Inserm), Mattia Arrigo(University Hospital of Zurich), Malha Sadoune(Inserm), Alain Cohen‐Solal(Inserm), Jean‐Marie Launay(Université Claude Bernard Lyon 1), Nicolas Vodovar(Institut Pasteur), Florence Beauvais(Hôpital Lariboisière), François Picard(Université de Bordeaux), Théo Pezel(Délégation Paris 5)
Cited by 153
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology
|European Journal of Preventive Cardiology|2020|924
State of the Art: Using Natriuretic Peptide Levels in Clinical Practice
|European Journal of Heart Failure|2008|837